Stifel Financial Corp Evolus, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Evolus, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 144,024 shares of EOLS stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

144,024

Previous 143,822 0.14%

Holding current value

$1.57 Million

Previous $1.56 Million 49.55%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.66 - $17.48 $2,153 - $3,530	202 Added 0.14%	144,024 $2.33 Million
Q2 2024 Aug 13, 2024	SELL	$10.45 - $13.76 $11,327 - $14,915	-1,084 Reduced 0.75%	143,822 $1.56 Million
Q1 2024 May 13, 2024	SELL	$9.99 - $14.91 $33,366 - $49,799	-3,340 Reduced 2.25%	144,906 $2.03 Million
Q4 2023 Feb 12, 2024	BUY	$7.6 - $10.53 $53,853 - $74,615	7,086 Added 5.02%	148,246 $1.56 Million
Q3 2023 Nov 13, 2023	BUY	$7.15 - $10.2 $127,355 - $181,682	17,812 Added 14.44%	141,160 $1.29 Million
Q2 2023 Aug 14, 2023	BUY	$7.23 - $10.52 $22,319 - $32,475	3,087 Added 2.57%	123,348 $896,000
Q1 2023 May 12, 2023	BUY	$7.81 - $11.05 $63,823 - $90,300	8,172 Added 7.29%	120,261 $1.02 Million
Q4 2022 Feb 13, 2023	SELL	$6.52 - $8.95 $66,484 - $91,263	-10,197 Reduced 8.34%	112,089 $841,000
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $74,821 - $132,288	9,642 Added 8.56%	122,286 $984,000
Q2 2022 Aug 15, 2022	BUY	$10.22 - $13.94 $617,502 - $842,268	60,421 Added 115.7%	112,644 $1.31 Million
Q1 2022 May 13, 2022	SELL	$5.22 - $11.78 $10,440 - $23,560	-2,000 Reduced 3.69%	52,223 $586,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $38,664 - $60,336	-7,200 Reduced 11.72%	54,223 $353,000
Q3 2021 Nov 15, 2021	BUY	$7.36 - $13.67 $15,824 - $29,390	2,150 Added 3.63%	61,423 $468,000
Q2 2021 Aug 13, 2021	BUY	$8.42 - $13.96 $56,835 - $94,230	6,750 Added 12.85%	59,273 $750,000
Q1 2021 May 14, 2021	BUY	$3.2 - $16.51 $45,168 - $233,038	14,115 Added 36.75%	52,523 $682,000
Q4 2020 Feb 12, 2021	SELL	$2.92 - $4.84 $36,356 - $60,262	-12,451 Reduced 24.48%	38,408 $129,000
Q3 2020 Nov 16, 2020	SELL	$3.03 - $5.48 $35,996 - $65,102	-11,880 Reduced 18.94%	50,859 $199,000
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.17 $34,000 - $59,429	9,632 Added 18.14%	62,739 $333,000
Q1 2020 May 14, 2020	BUY	$3.53 - $12.21 $187,467 - $648,436	53,107 New	53,107 $209,000

Others Institutions Holding EOLS

# of Institutions

168

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $611M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Evolus, Inc. Transaction History